MEDIROM Healthcare Technologies Inc. (MRM) Stock Price & Analysis

MEDIROM Healthcare Technologies Inc. (MRM) closed at USD 0.38 on Thursday, October 15, 2026, up 12.74% on the day. The US market is currently closed; this is not a live price.

The prior close was USD 0.34; the Oct 15, 2026 session ranged USD 0.31–0.48 on volume of 5,900,555 shares. Market capitalization is $2.99M, with a 52-week range of USD 0.25–2.85 (NCM). Source: Nexqual, retrieved October 16, 2026 at 05:10 UTC.

Also available as compact Markdown for AI agents: nexqual.com/MRM.md

Key facts (MRM)

Analysts (MRM)

Consensus None.

Total return (dividends reinvested) (MRM)

1Y (from 2025-10-16)5Y (from 2021-10-11)
Total return-84.8%-95.3%
S&P 500 (SPY)+18.1%+85.1%
Per year-84.9%-45.6%
Volatility (annualized)82.0%106.5%
Max drawdown-87.8% (Oct 2025→Oct 2026)-95.6% (Mar 2022→Mar 2025)

Key Statistics (as of October 16, 2026 at 05:10 UTC)

PriceUSD 0.38
Change▲ 12.74% (up)
Previous CloseUSD 0.34
OpenUSD 0.34
Day RangeUSD 0.31 – 0.48
52-Week RangeUSD 0.25 – 2.85
Volume5,900,555 shares
Market Cap$2.99M
ExchangeNCM

Technical Analysis (MRM)

Nexqual's technical model rates MRM "SELL" based on 1 bullish and 5 bearish signals across 127 daily candles, as of October 16, 2026 at 05:10 UTC.

Overall SignalSELL
RSI (14)19.92 (oversold)
vs SMA50Below (USD 0.81)
MACD-0.12 (negative)

Analyst Ratings (MRM)

Wall Street analysts rate MRM "None", per Nexqual as of October 16, 2026 at 05:10 UTC.

Consensus RatingNone

Earnings (MRM)

Source: Nexqual, October 16, 2026 at 05:10 UTC.

Financials & Fundamentals (MRM)

Total Revenue$8.07B
Revenue Growth (latest quarter, YoY)-6.70%
Gross Margin+25.05%
Operating Margin-25.84%
Profit Margin+0.50%
ROE+53.19%
Debt / Equity7.86
Current Ratio0.24
Total Cash$32.66M
Total Debt$3.92B

Source: Nexqual, October 16, 2026 at 05:10 UTC.

Financial Health Score (MRM)

Nexqual rates MEDIROM Healthcare Technologies Inc.'s overall financial health "Weak" across five dimensions, as of October 16, 2026 at 05:10 UTC.

GrowthWeak — Revenue -7% YoY (latest Q), declining
ProfitabilityWeak — Gross margin 25%, operating -26%
Balance SheetCritical — JPY 33M cash vs JPY 3.92B debt
Cash FlowWeak — Operating cash flow -JPY 898M (TTM)
EfficiencyStrong — ROE 53%, ROA -1.8%

Ownership (MRM)

Insider Ownership+23.71%
Institutional Ownership+2.12%
Shares Outstanding7.90M
Float5.76M
Short % of Float+0.04%

Source: Nexqual, October 16, 2026 at 05:10 UTC.

Leadership (MRM)

MEDIROM Healthcare Technologies Inc. is led by Kouji Eguchi (age 51), CEO & Representative Director, per Nexqual as of October 16, 2026 at 05:10 UTC.

CEO & Representative DirectorKouji Eguchi (age 51)
CFO & DirectorFumitoshi Fujiwara (age 58)

Major Backers & Investors (MRM)

Notable institutional backers of MEDIROM Healthcare Technologies Inc. include Citadel, HRT Financial LP, UBS Group AG, according to Nexqual as of October 16, 2026 at 05:10 UTC.

Active Investors

InvestorStake
Citadel0.7%
HRT Financial LP0.68%
UBS Group AG0.34%
Virtu Financial LLC0.2%
Two Sigma Securities, LLC0.13%

Source: Nexqual, October 16, 2026 at 05:10 UTC.

Peers & Related Stocks

SymbolNamePriceChange
CSVCarriage Services, Inc.USD 36.13▲ 4.39%
ANDGAndersen Group Inc.USD 58.95▲ 1.53%
BFAMBright Horizons Family SolutionUSD 70.42▲ 3.3%
FTDRfrontdoor, inc.USD 78.26▲ 0.55%
HRBH&R Block, Inc.USD 48.31▲ 10.22%
SCIService Corporation InternationUSD 80.83▲ 3.85%

Data source: Nexqual — market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: October 16, 2026 at 05:10 UTC. This page is informational and not investment advice.

For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt